NASDAQ : BTAI

BioXcel Therapeutics, Inc. — Institutional Ownership

$0.9495 USD

$0.05 (5.3%)

Volume
303.96K
Average Volume
923.25K
Market Capitalization
$29.32M
P/E Ratio
-0.14
Dividend Yield
0.00%
Price Target
$10.00
Year High
$8.08
Year Low
$0.74
Day High
Day Low
Payout Ratio
$0.00
Current Ratio
$0.62
Institutional Ownership Summary
Institutional Ownership %

%

Investors Holding

change: 0.0 | last:
Increased Positions

change: 0.0 | last:
Reduced Positions

change: 0.0 | last:
New Positions

change: 0.0 | last:
Sold Positions

change: 0.0 | last:
Total Calls

-

Total Puts

-

Put-Call Ratio

change: 0.0 | last:
Total Invested

-

Beneficial Ownership Filings
Filing Date Reporting Person Amount Beneficially Owned % of Class
2026-05-15 Armistice Capital, LLC 1.91M 7.05%
2026-03-30 Qatar Investment Authority 156.07K 0.60%
2026-02-09 Integrated Core Strategies (US) LLC 1.83M 8.40%
2025-10-01 Integrated Core Strategies (US) LLC 1.03M 5.20%
2025-05-15 Oaktree Fund Advisors, LLC 51429.0 0.83%
2025-05-15 Armistice Capital, LLC 288.13K 4.99%
2025-02-14 Armistice Capital, LLC 5M 9.99%
2023-09-28 Vimal Mehta 9.5M 32.50%
2023-09-28 BioXcel LLC 8.55M 29.20%
2023-09-28 BioXcel Holdings, Inc. 8.55M 29.20%
2023-02-03 (1) BlackRock, Inc. 1.46M 5.20%
2023-02-02 Adage Capital Advisors, L.L.C. 1.55M 5.53%
2023-02-02 Adage Capital Partners GP, L.L.C. 1.55M 5.53%
2023-02-02 Adage Capital Partners, L.P. 1.55M 5.53%
2023-02-02 Robert Atchinson 1.55M 5.53%
2023-02-02 Phillip Gross 1.55M 5.53%
2022-02-14 13-4064930 1.51M 5.40%
2022-02-09 STATE STREET CORPORATION 1.35M 4.81%
2021-02-16 Vimal Mehta 9.64M 38.59%
2021-02-16 Krishnan Nandabalan 9.5M 38.23%
2021-02-16 BioXcel LLC 9.02M 37.02%
2021-02-16 BioXcel Holdings, Inc. 9.02M 37.02%
2021-02-11 SSGA FUNDS MANAGEMENT, INC. 1.47M 6.03%
2021-02-11 STATE STREET CORPORATION 1.67M 6.87%
2018-04-10 FMR LLC 1.67M 10.65%
BTAI Enterprise Value History
Annual
Date Stock Price Shares Outstanding Market Cap Cash & Equivalents Total Debt Enterprise Value
2025-12-31 $1.60 12.21M $19.53M $28.42M $109.66M $100.78M
2024-12-31 $5.98 2.54M $15.16M $29.85M $102.95M $88.25M
2023-12-31 $47.20 1.82M $85.93M $65.22M $101.38M $122.09M
2022-12-31 $343.68 1.75M $601.76M $193.72M $94.16M $502.19M
2021-12-31 $325.28 1.65M $536.16M $232.97M $1.4M $304.59M
2020-12-31 $739.20 1.36M $1B $213.12M $1.64M $790.27M
2019-12-31 $233.76 1.02M $237.98M $32.43M $1.03M $206.59M
2018-12-31 $61.76 910.72K $56.25M $42.56M -$ $13.68M
2017-12-31 $176.48 1.03M $181.59M $887K $371K $181.08M
2016-12-31 $176.48 1.03M $181.59M -$ -$ $181.59M
Quarterly
Date Stock Price Shares Outstanding Market Cap Cash & Equivalents Total Debt Enterprise Value
2026-03-31 $1.34 12.21M $16.36M $17.18M $100.29M $99.47M
2025-12-31 $1.60 12.21M $19.53M $28.42M $109.66M $100.78M
2025-09-30 $2.56 14.2M $36.34M $37.32M $109.29M $108.31M
2025-06-30 $1.81 7.84M $14.2M $17.44M $108.94M $105.7M
2025-03-31 $2.03 4.83M $9.81M $31.01M $105.88M $84.68M
2024-12-31 $5.98 3.04M $18.17M $29.85M $102.95M $91.27M
2024-09-30 $9.76 2.65M $25.86M $40.39M $104.97M $90.44M
2024-06-30 $18.72 2.52M $47.1M $56.27M $103.62M $94.45M
2024-03-31 $45.12 1.93M $87.05M $74.14M $102.34M $115.24M
2023-12-31 $47.20 1.84M $86.87M $65.22M $101.38M $123.04M
2023-09-30 $40.48 1.83M $74.05M $89.96M $99.96M $84.05M
2023-06-30 $106.56 1.82M $194.39M $127.54M $97.8M $164.64M